SCHOTT Committed to Further Investments in Brazilian Pharma Packaging Plant
News Apr 23, 2015
On the occasion of its 80th manufacturing anniversary in Brazil SCHOTT has underscored its commitment to continue to invest in its pharmaceutical packaging plant in Itupeva, Brazil. By doing so, the company plans to support the growing domestic pharmaceutical companies by supplying high-quality pharma packaging that is manufactured locally.
The facility located near São Paulo is home to production of high-quality ampoules, vials, and cartridges. Ever since SCHOTT entered the Brazilian market, the company has constantly modernized the Itupeva plant, which manufactures according to GMP principles (Good Manufacturing Practice).
In the last fiscal year alone, SCHOTT has invested BRL 15 million in this strategically important facility. The products manufactured in Itupeva are used by pharma companies to safely store and administer life-saving medications to patients.
Thanks to a worldwide production network of 16 plants, SCHOTT is the only packaging manufacturer that is present in all of the so-called BRIC countries, the fast-growing pharma markets in Brazil, Russia, India and China. “Brazil in particular is a very interesting market for us,” confirms Andreas Reisse, Executive Vice President of SCHOTT’s Pharmaceutical Systems Business Unit. “With these investments, we want to make sure that our South American customers are supplied in the best possible way,” he adds.
Good market prospects
A recent report from IMS Health revealed that Brazil will most likely be ranked fifth among the major pharma markets in the world in 2018, displacing Germany in the process. This is for good reason: Brazil is said to be the only country in the world that has a universal and free public health care system. Secondly, the average income is on the rise, and more and more Brazilians are joining private health plans. Finally, an ever-aging population demands more health care. “The pharmaceutical industry in Brazil can make significant progress based on this growth in health care expenditure. And SCHOTT will be a very supportive partner when it comes to realizing these growth objectives by supplying its customers with the highest quality pharmaceutical packaging”, says Jürgen Buhr, Director of SCHOTT Pharmaceutical Systems in Brazil.
With its model plant in Itupeva and the modernization process that lies ahead, SCHOTT is in an excellent position to be able to support the growing pharma industry in Brazil. The plant’s production lines run 24 hours a day, 365 days a year, contributing significantly to the 9 billion units the company produces worldwide every year. Today, some 500 employees work at the 170,000 square meter plant in Itupeva. Production meets the highest international standards of Quality (ISO 9000), Environment (ISO 14000), Occupational Health and Safety Management (OHSAS 18000) and, last but not least, Pharmaceutical Production (GMP – Good Manufacturing Practice ISO 15378).
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Medherant Expands Team with Appointment of David Davies as Head of DevelopmentNews
Medherant Ltd, a leader in next-generation transdermal drug delivery, is pleased to announce the appointment of a new senior executive, David Davies, as Head of Development.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018